The role of narrowband UV-B plus alefacept combination therapy in the treatment of psoriasis

Archives of Dermatology

Volumn 144, Issue 8, 2008, Pages 1067-1068

  Jacobe, Heidi ^a   Winterfield, Laura ^b   Kim, Flora ^b   Huet Adams, Beverley ^b   Cayce, Rachael ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; PLACEBO;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; HUMAN; LETTER; MALE; NARROWBAND ULTRAVIOLET B PHOTOTHERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; THERAPY EFFECT; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION;

ANALYSIS OF VARIANCE; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PSORIASIS; RECOMBINANT FUSION PROTEINS; SEVERITY OF ILLNESS INDEX; SKIN; STATISTICS AS TOPIC; ULTRAVIOLET THERAPY;

EID: 49949112689     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.8.1067     Document Type: Letter

References (1)

1. Legat FJ, Hofer A, Wackernagel A, et al. Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis. Arch Dermatol. 2007;143(8):1016-1022.